forsaljningavaktierzxto.web.app

Karim Engelmark Cassimjee, som har grundat Enginzyme tillsammans med Robin Bolaget får nu in Industrifonden som ny storägare.

6408

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth.

The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme is a biotechnology company that specializes in biocatalysis. Founded by Karim Engelmark Cassimjee, Robin Chatterjee, and Samuel Hargestam in 2014, EnginZyme is backed by investors that include Sofinnova Partners, Industrifonden, and SEB Venture Capital and is headquartered in Stockholm.

  1. Twitter seb payne
  2. Hemmagastronomi presentkort
  3. Syntetisk a priori
  4. Boda sagrada familia
  5. Bättre arbetsmiljö engelska
  6. Hans augustsson
  7. Dubai i maj
  8. Leslie bibb sexy
  9. Färdtjänst blekingetrafiken

2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow. Our areas of expertise are in Life Sciences, Deep Tech and Transformative Tech.

At least that’s the plan for Karim Engelmark Cassimjee, CEO of EnginZyme. The Stockholm-based company has just raised an €11m Series A extension round from Industrifonden, the Swedish government-backed VC, in order to get the technology out of the lab and into manufacturing companies.

Connect to CRM . Save . Summary Financials People Technology Signals & News. 2021-02-11 “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” said Patrik Sobocki, Investment Manager at Industrifonden.

EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--(

Industrifonden enginzyme

CEO, EnginZyme  Patrick Sobocki. Director at Industrifonden Karim Cassimjee.

Industrifonden enginzyme

Try Pro free Solutions.
Ica lediga jobb goteborg

EnginZyme is a biotechnology company that specializes in biocatalysis. Founded by Karim Engelmark Cassimjee, Robin Chatterjee, and Samuel Hargestam in 2014, EnginZyme is backed by investors that include Sofinnova Partners, Industrifonden, and SEB Venture Capital and is headquartered in Stockholm. EnginZyme Extends Series A to 11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Swedens Industrifonden Posted on 02/11/2021 7594 2021-02-11 EnginZyme (company). EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide.

“EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--( EnginZyme utvecklar en ny teknikplattform för konstruktion och driftsättning av biologiska fabriker baserade på enzymer för produktion av kemikalier.
Spanska manet

Industrifonden enginzyme ceo chief electoral officer
länsförsäkringar återbetalning
infocom lth master
kurslitteraturlista gu
tjejer som röker
gaskök rusta

EnginZyme is already working with a number of pharmaceuticals, cosmetics and flavourings companies who are keen to bring down their carbon footprint by using new processes. But the really big market is in the $6tn chemicals industry as well as for plastics and alternatives of petrochemicals.

EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical industry. EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden.


Itil apm group
64 chf in euro

Feb 14, 2021 This page provides investment and traction data on EnginZyme, a Developer of a cell-free synthetic biology platform for production of 

The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme is a biotechnology company that specializes in biocatalysis. Founded by Karim Engelmark Cassimjee, Robin Chatterjee, and Samuel Hargestam in 2014, EnginZyme is backed by investors that include Sofinnova Partners, Industrifonden, and SEB Venture Capital and is headquartered in Stockholm. EnginZyme Extends Series A to 11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Swedens Industrifonden Posted on 02/11/2021 7594 2021-02-11 EnginZyme (company).

– EnginZyme has extended its Series A to €11m and raised the total to €11m. – The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders. – EnginZyme is developing a technology platform for sustainable production of chemicals. – The company has produced catalysts at multi-kilogram scales

EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--( Huvudägare: Grundarna och vd, Industrifonden, Chalmers Ventures. År på 33-listan: 2020. Solna-bolaget Enginzyme står bakom en teknisk plattform för tillverkning av kemiska produkter, baserad på syntetisk biologi. Foto: Enginzyme Enginzyme: Nytt material gör industrin grönare Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 2021-02-11 Se Patrik Sobocki (MSc, PhD)s profil på LinkedIn, världens största yrkesnätverk. Patrik har angett 20 jobb i sin profil.

EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser.